01 1Viatris
01 1EMTRICITABINE (PROCESS-III)
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-23
Pay. Date : 2017-03-01
DMF Number : 31457
Submission : 2017-03-10
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is EMTRICITABINE (PROCESS-III), with a corresponding US DMF Number 31457.
Remarkably, this DMF maintains an Active status since its submission on March 10, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 23, 2017, and payment made on March 01, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
